Shop Apotheke Europe N.V. owns and operates online pharmacies in Germany, Belgium, Austria, Switzerland, the Netherlands, France, Italy, and Spain. More Details
High growth potential with excellent balance sheet.
Share Price & News
How has Shop Apotheke Europe's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: SAE is more volatile than 90% of German stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: SAE's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of German stocks.
7 Day Return
DE Online Retail
1 Year Return
DE Online Retail
Return vs Industry: SAE exceeded the German Online Retail industry which returned 94.1% over the past year.
Return vs Market: SAE exceeded the German Market which returned 1.1% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Shop Apotheke Europe's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall StAnalysts Are Updating Their Shop Apotheke Europe N.V. (ETR:SAE) Estimates After Its Third-Quarter Results
4 weeks ago | Simply Wall StIntroducing Shop Apotheke Europe (ETR:SAE), The Stock That Zoomed 293% In The Last Year
1 month ago | Simply Wall StHow Much Are Shop Apotheke Europe N.V. (ETR:SAE) Insiders Taking Off The Table?
Is Shop Apotheke Europe undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate SAE's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate SAE's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: SAE is unprofitable, so we can't compare its PE Ratio to the DE Online Retail industry average.
PE vs Market: SAE is unprofitable, so we can't compare its PE Ratio to the German market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate SAE's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: SAE's PB Ratio (5.8x) is in line with the DE Online Retail industry average.
How is Shop Apotheke Europe forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SAE is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.2%).
Earnings vs Market: SAE is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: SAE's is expected to become profitable in the next 3 years.
Revenue vs Market: SAE's revenue (24.7% per year) is forecast to grow faster than the German market (5.8% per year).
High Growth Revenue: SAE's revenue (24.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SAE's Return on Equity is forecast to be low in 3 years time (3.6%).
How has Shop Apotheke Europe performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SAE is currently unprofitable.
Growing Profit Margin: SAE is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: SAE is unprofitable, and losses have increased over the past 5 years at a rate of 17.1% per year.
Accelerating Growth: Unable to compare SAE's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SAE is unprofitable, making it difficult to compare its past year earnings growth to the Online Retail industry (30.6%).
Return on Equity
High ROE: SAE has a negative Return on Equity (-5.1%), as it is currently unprofitable.
How is Shop Apotheke Europe's financial position?
Financial Position Analysis
Short Term Liabilities: SAE's short term assets (€281.2M) exceed its short term liabilities (€85.6M).
Long Term Liabilities: SAE's short term assets (€281.2M) exceed its long term liabilities (€163.7M).
Debt to Equity History and Analysis
Debt Level: SAE's debt to equity ratio (54.5%) is considered high.
Reducing Debt: SAE's debt to equity ratio has reduced from 210.6% to 54.5% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SAE has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: SAE has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 28.5% each year
What is Shop Apotheke Europe current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate SAE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SAE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if SAE's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SAE's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of SAE's dividend in 3 years as they are not forecast to pay a notable one for the German market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Stefan Feltens (55 yo)
Mr. Stefan Feltens has been the Chairman of Managing Board and Chief Executive Officer at Shop Apotheke Europe N.V., since January 1, 2019 and served as its Manager of Purchasing and Human Resources since ...
CEO Compensation Analysis
Compensation vs Market: Stefan's total compensation ($USD186.64K) is below average for companies of similar size in the German market ($USD2.50M).
Compensation vs Earnings: Insufficient data to compare Stefan's compensation with company performance.
|Chairman of the Supervisory Board||4.83yrs||€30.00k||no data|
|Member of Supervisory Board||4.83yrs||€20.00k||no data|
|Vice Chairman of the Supervisory Board||4.83yrs||€20.00k||no data|
|Member of Supervisory Board||4.83yrs||€20.00k||0.022% |
Experienced Board: SAE's board of directors are considered experienced (4.8 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 33.2%.
Shop Apotheke Europe N.V.'s company bio, employee growth, exchange listings and data sources
- Name: Shop Apotheke Europe N.V.
- Ticker: SAE
- Exchange: XTRA
- Founded: 2001
- Industry: Internet and Direct Marketing Retail
- Sector: Retail
- Market Cap: €2.238b
- Shares outstanding: 17.94m
- Website: https://shop-apotheke-europe.com
Number of Employees
- Shop Apotheke Europe N.V.
- Dirk Hartogweg 14
- 5928 LV
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|SAE||XTRA (XETRA Trading Platform)||Yes||Ordinary Shares||DE||EUR||Oct 2016|
|SAE||DB (Deutsche Boerse AG)||Yes||Ordinary Shares||DE||EUR||Oct 2016|
|0RJT||LSE (London Stock Exchange)||Yes||Ordinary Shares||GB||EUR||Oct 2016|
|SHOP||WBAG (Wiener Boerse AG)||Yes||Ordinary Shares||AT||EUR||Oct 2016|
|SAED||BATS-CHIXE (BATS 'Chi-X Europe')||Yes||Ordinary Shares||GB||EUR||Oct 2016|
|SAE||ETLX (Eurotlx)||Yes||Ordinary Shares||IT||EUR||Oct 2016|
|SAEY.Y||OTCPK (Pink Sheets LLC)||UNSPONSORED ADS||US||USD||Oct 2020|
Shop Apotheke Europe N.V. owns and operates online pharmacies in Germany, Belgium, Austria, Switzerland, the Netherlands, France, Italy, and Spain. It provides prescription medications, over-the-counter me...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/11/25 20:43|
|End of Day Share Price||2020/11/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.